hrcak mascot   Srce   HID

Stručni rad

CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part III: neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer, cancer of the bile ducts

Natalija Dedić Plavetić
Renata Kelemenić Dražin
Renata Dobrila Dintinjana
Mladen Radić
Juraj Prejac
Zrinka Mišetić Dolić
Mirjana Pavlović
Mate Škegro
Robert Šeparović
Damir Vrbanec

Puni tekst: hrvatski, pdf (826 KB) str. 0-0 preuzimanja: 1.127* citiraj
APA 6th Edition
Dedić Plavetić, N., Kelemenić Dražin, R., Dintinjana, R.D., Radić, M., Prejac, J., Mišetić Dolić, Z., ... Vrbanec, D. (2016). PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova. Liječnički vjesnik, 138 (7-8), 0-0. Preuzeto s https://hrcak.srce.hr/172868
MLA 8th Edition
Dedić Plavetić, Natalija, et al. "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova." Liječnički vjesnik, vol. 138, br. 7-8, 2016, str. 0-0. https://hrcak.srce.hr/172868. Citirano 16.10.2019.
Chicago 17th Edition
Dedić Plavetić, Natalija, Renata Kelemenić Dražin, Renata Dobrila Dintinjana, Mladen Radić, Juraj Prejac, Zrinka Mišetić Dolić, Mirjana Pavlović, Mate Škegro, Robert Šeparović i Damir Vrbanec. "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova." Liječnički vjesnik 138, br. 7-8 (2016): 0-0. https://hrcak.srce.hr/172868
Harvard
Dedić Plavetić, N., et al. (2016). 'PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova', Liječnički vjesnik, 138(7-8), str. 0-0. Preuzeto s: https://hrcak.srce.hr/172868 (Datum pristupa: 16.10.2019.)
Vancouver
Dedić Plavetić N, Kelemenić Dražin R, Dintinjana RD, Radić M, Prejac J, Mišetić Dolić Z i sur. PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova. Liječnički vjesnik [Internet]. 2016 [pristupljeno 16.10.2019.];138(7-8):0-0. Dostupno na: https://hrcak.srce.hr/172868
IEEE
N. Dedić Plavetić, et al., "PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova", Liječnički vjesnik, vol.138, br. 7-8, str. 0-0, 2016. [Online]. Dostupno na: https://hrcak.srce.hr/172868. [Citirano: 16.10.2019.]

Sažetak
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow-up of oncological patients after primary treatment, in patients with neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer and cancer of the bile ducts.

Ključne riječi
Neuroendocrine tumors – diagnosis, pathology, therapy; Carcinoma, hepatocellular – diagnosis, therapy; Liver neoplasms – diagnosis, therapy; Pancreatic neoplasms – diagnosis, pathology, therapy; Adenocarcinoma – diagnosis, therapy; Gallbladder neoplasms – diagnosis, therapy; Bile duct neoplasms – diagnosis, therapy; Medical oncology – standards; Practice guidelines as topic – standards; Follow-up studies; Croatia

Hrčak ID: 172868

URI
https://hrcak.srce.hr/172868

[hrvatski]

Posjeta: 1.285 *